Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators.
Publication
, Preprint
Pittman Ballard, CA; Goff, KM; Patel, MP; Walsh, KM; Monje, M; Ostrom, QT
September 27, 2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Pittman Ballard, C. A., Goff, K. M., Patel, M. P., Walsh, K. M., Monje, M., & Ostrom, Q. T. (2025). Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. https://doi.org/10.1101/2025.09.24.25335799
Pittman Ballard, Christine Ann, Kevin M. Goff, Mallika P. Patel, Kyle M. Walsh, Michelle Monje, and Quinn T. Ostrom. “Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators.,” September 27, 2025. https://doi.org/10.1101/2025.09.24.25335799.
Pittman Ballard CA, Goff KM, Patel MP, Walsh KM, Monje M, Ostrom QT. Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. 2025.
Pittman Ballard, Christine Ann, et al. Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. 27 Sept. 2025. Pubmed, doi:10.1101/2025.09.24.25335799.
Pittman Ballard CA, Goff KM, Patel MP, Walsh KM, Monje M, Ostrom QT. Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. 2025.